BioLife Solutions, Inc. (BLFS) News

BioLife Solutions, Inc. (BLFS): $22.87

-0.88 (-3.71%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BLFS News Items

BLFS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BLFS News Highlights

  • BLFS's 30 day story count now stands at 4.
  • Over the past 20 days, the trend for BLFS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • GENE, LI and LU are the most mentioned tickers in articles about BLFS.

Latest BLFS News From Around the Web

Below are the latest news stories about Biolife Solutions Inc that investors may wish to consider to help them evaluate BLFS as an investment opportunity.

BioLife Solutions to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on February 28, 2022

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2021 financial results will be released after market close on Monday, February 28th. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a genera

Yahoo | February 21, 2022

PETQ or BLFS: Which Is the Better Value Stock Right Now?

PETQ vs. BLFS: Which Stock Is the Better Value Option?

Yahoo | February 11, 2022

Is BioLife Solutions (NASDAQ:BLFS) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Yahoo | February 2, 2022

Horan Capital Advisors, LLC. Buys BorgWarner Inc, Cincinnati Bancorp Inc, Schwab Emerging ...

Cincinnati, OH, based Investment company Horan Capital Advisors, LLC. (Current Portfolio) buys BorgWarner Inc, Cincinnati Bancorp Inc, Schwab Emerging Markets Equity ETF, Intercontinental Exchange Inc, Coca-Cola Co, sells AT&T Inc, iShares Core MSCI Emerging Markets ETF, Eaton Corp PLC, BioLife Solutions Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Horan Capital Advisors, LLC..

Yahoo | February 1, 2022

Peoples Bank Buys BioLife Solutions Inc, iShares 0-5 Year TIPS Bond ETF, SPDR Portfolio Short ...

Investment company Peoples Bank (Current Portfolio) buys BioLife Solutions Inc, iShares 0-5 Year TIPS Bond ETF, SPDR Portfolio Short Term Corporate Bond ETF, General Motors Co, Air Transport Services Group Inc, sells Cummins Inc, Rio Tinto PLC, Citigroup Inc, Pioneer Natural Resources Co, Dow Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Peoples Bank .

Yahoo | January 27, 2022

BioLife Solutions Announces Preliminary 2021 Revenue of $119 Million, Up 148% Over 2020

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced preliminary revenue for the fourth quarter and full year 2021.

Yahoo | January 10, 2022

BioLife Solutions Collaborates with Seattle Children's to Improve Viral Vector and Cell and Gene Therapy Manufacturing

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets, today announced an extended collaboration with Seattle Children's Therapeutics, a venture at Seattle Children's, bringing cutting edge, curative technologies and therapies to defeat pediatric cancer and other diseases that impact children. The collaboration will focus on establishing best practices in biopreservation and closed

Yahoo | January 4, 2022

Stephens Investment Management Group LLC Has $9.27 Million Stake in BioLife Solutions, Inc. (NASDAQ:BLFS)

Stephens Investment Management Group LLC lifted its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS) by 72.6% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 219,059 shares of the medical equipment providers stock after acquiring an additional 92,132 shares during the period. Stephens Investment Management Group LLCs holdings in BioLife Solutions were []

Transcript Daily | December 16, 2021

Biolife Solutions Inc (BLFS) CEO Michael Rice Sold $1.1 million of Shares

CEO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Michael Rice (insider trades) sold 33,332 shares of BLFS on 12/15/2021 at an average price of $33.31 a share.

Yahoo | December 16, 2021

UNICEF Selects Ultra-Low Temperature (ULT) Freezers from BioLife Solutions to Extend Thermal Stability of COVID-19 Vaccines

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced a partnership with UNICEF to extend thermal stability of temperature-sensitive COVID-19 vaccines in developing communities in Africa, the Middle East and South America where limited power infrastructure and extreme environmental conditions make it difficult for most ULT freezers to remain operational.

Yahoo | December 16, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4879 seconds.